|1.||Abdel-Magid, Ahmed F: 1 article (11/2013)|
|2.||Méndez, Carmen: 1 article (01/2009)|
|3.||Olano, Carlos: 1 article (01/2009)|
|4.||Salas, José A: 1 article (01/2009)|
|5.||Yang, Sheng-Huei: 1 article (07/2007)|
|6.||Wu, Ming-Jung: 1 article (07/2007)|
|7.||Lo, Yu-Hsiang: 1 article (07/2007)|
|8.||Lin, I-Ling: 1 article (07/2007)|
|9.||Lin, Chi-Fong: 1 article (07/2007)|
|10.||Hsu, Cheng-Chung: 1 article (07/2007)|
11/14/2013 - "New synthetic enediynes and their conjugates may provide effective treatment for cancer."
07/01/2007 - "A series of acyclic enediynes showing significant inhibition on the growth of tumor cancer is disclosed. "
01/01/1995 - "The relatively low sensitivity of many established cell lines to synthetic enediynes suggests a discrepancy between cell culture and in vivo tumor cytotoxicities. "
10/01/2006 - "This enediyne ligand, developed as a potential alternative to the highly cytotoxic natural enediynes, some of which have been successfully used as anti-tumor agents, has previously been shown to interact with DNA through frank strand scission as well as via the formation of adducts that lead to 2'-deoxycytidine-specific cleavage. "
03/02/2004 - "Further, we provide evidence that the activated enediynes underwent covalent crosscoupling with the aldolase Ab, which appears to be a limiting factor of their tumor cell growth-inhibiting activity and should be of general interest in the field of enediyne chemotherapy. "
01/01/1994 - "These results imply that enediynes such as NCS may be useful in ex vivo purging regimens and in in vivo treatment of microscopic residual disease in patients with neuroblastoma."
03/15/1996 - "The present studies suggest that enediynes that require reductive activation might be critically useful agents in the therapy of tumors such as neuroblastomas and estrogen-responsive breast cancers, the resistance of which is related to up-regulation of Bcl-2."
|3.||Kaposi Sarcoma (Kaposi's Sarcoma)
|4.||Acquired Immunodeficiency Syndrome (AIDS)
|5.||Peptide Hydrolases (Proteases)
|6.||Fructose-Bisphosphate Aldolase (Aldolase)
|8.||Type I DNA Topoisomerases (Topoisomerase I)
|9.||DNA (Deoxyribonucleic Acid)
|1.||Drug Therapy (Chemotherapy)